Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (101-110 of 462) with videos related to

Pageof 47
Sort By:
Gut|February 7, 2019
Microscopic heterogeneity in ulcerative colitis: implications for microscopic measurement of disease activityNoam Harpaz, Samuel Ballentine, Jean-Frederic Colombel, et al.
Inflammatory Bowel Diseases|August 24, 2021
Noninfectious Pulmonary Complications Associated With Anti-Integrin Therapy: A Case Report and Systematic Review of the LiteratureDavid Dulaney, Priya Dave, Samantha Walsh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2023
Per- and Poly-Fluoroalkyl Substances Exposure Is Associated With Later Occurrence of Inflammatory Bowel DiseaseManasi Agrawal, Vishal Midya, Amith Maroli, et al.
Gut|March 30, 2019
Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysisBerkeley N Limketkai, Shailja C Shah, Ikuo Hirano, et al.
Inflammatory Bowel Diseases|October 12, 2004
Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's diseaseMimouna Seddik, Hugues Meliez, David Seguy, et al.
Gastroenterology|February 5, 2023
ReplyManasi Agrawal, Heidi S Christensen, Jean-Frederic Colombel, et al.
Inflammatory Bowel Diseases|August 1, 2022
Racial Difference in Efficacy of Golimumab in Ulcerative ColitisRuby Greywoode, Francesca Petralia, Thomas A Ullman, et al.
Gastroenterologie Clinique Et Biologique|March 4, 2006
[Fluorescent imaging in digestive endoscopy]Serge Mordon, Vincent Maunoury, Philippe Bulois, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 11, 2025
Primary EBV Infection in Late Childhood, But Not in Adulthood, is Associated With Lower Risk of Inflammatory Bowel Disease in a Population-Based CohortManasi Agrawal, Kristine H Allin, Anne Vinkel Hansen, et al.
Inflammatory Bowel Diseases|September 18, 2021
Impact of Thiopurine Exposure on Immunogenicity to Infliximab Is Negligible in the Setting of Elevated Infliximab ConcentrationsRyan C Ungaro, Jean-Frederic Colombel, Marla C Dubinsky, et al.
Pageof 47

Showing results (101-110 of 462) with videos related to

Sort By:
Pageof 47
Gut|February 7, 2019
Microscopic heterogeneity in ulcerative colitis: implications for microscopic measurement of disease activityNoam Harpaz, Samuel Ballentine, Jean-Frederic Colombel, et al.
Inflammatory Bowel Diseases|August 24, 2021
Noninfectious Pulmonary Complications Associated With Anti-Integrin Therapy: A Case Report and Systematic Review of the LiteratureDavid Dulaney, Priya Dave, Samantha Walsh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2023
Per- and Poly-Fluoroalkyl Substances Exposure Is Associated With Later Occurrence of Inflammatory Bowel DiseaseManasi Agrawal, Vishal Midya, Amith Maroli, et al.
Gut|March 30, 2019
Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysisBerkeley N Limketkai, Shailja C Shah, Ikuo Hirano, et al.
Inflammatory Bowel Diseases|October 12, 2004
Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's diseaseMimouna Seddik, Hugues Meliez, David Seguy, et al.
Gastroenterology|February 5, 2023
ReplyManasi Agrawal, Heidi S Christensen, Jean-Frederic Colombel, et al.
Inflammatory Bowel Diseases|August 1, 2022
Racial Difference in Efficacy of Golimumab in Ulcerative ColitisRuby Greywoode, Francesca Petralia, Thomas A Ullman, et al.
Gastroenterologie Clinique Et Biologique|March 4, 2006
[Fluorescent imaging in digestive endoscopy]Serge Mordon, Vincent Maunoury, Philippe Bulois, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 11, 2025
Primary EBV Infection in Late Childhood, But Not in Adulthood, is Associated With Lower Risk of Inflammatory Bowel Disease in a Population-Based CohortManasi Agrawal, Kristine H Allin, Anne Vinkel Hansen, et al.
Inflammatory Bowel Diseases|September 18, 2021
Impact of Thiopurine Exposure on Immunogenicity to Infliximab Is Negligible in the Setting of Elevated Infliximab ConcentrationsRyan C Ungaro, Jean-Frederic Colombel, Marla C Dubinsky, et al.
Pageof 47